Maverick Capital’s Oscar Health OSCR Stock Holding History

Maverick Capital’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-213,095	Closed	-$4.57M	–	295
2025 Q2	$4.57M	Buy	+213,095	New	+$3.17M	0.07%	71

Other funds holding OSCR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Maverick Capital's OSCR Position: Q3 2025 in Review

Maverick Capital sold out of Oscar Health (OSCR) in Q3 2025, closing a stake of 213,095 shares — an estimated $4.57M sold.

Maverick Capital first reported a position in OSCR in Q2 2025 and held it in 1 quarter. The position peaked at $4.57M in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q3 2025.

Maverick Capital reported no remaining Oscar Health position as of Q3 2025 after selling out during the quarter.
Maverick Capital sold 213,095 Oscar Health shares in Q3 2025, an estimated $4.57M.
Maverick Capital first reported a position in Oscar Health in Q2 2025 and held it in 1 quarter.
Maverick Capital's Oscar Health position peaked at $4.57M in Q2 2025.
343 funds tracked by Wall St. Rank held Oscar Health as of Q3 2025.

Based on Maverick Capital's 13F filing for Q3 2025, filed 14 Nov 2025.